Last reviewed · How we verify
NCT02979730: FluProcess
Impact of Rapid Flu Testing in BMC ED
NA trial testing Core Lab Test in Influenza-Like Illness in 233 participants. Completed in 1 December 2017.
1 December 2017
Quick facts
| Lead sponsor | Boston Medical Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 233 |
| Start date | 7 February 2017 |
| Primary completion | 1 December 2017 |
| Estimated completion | 1 December 2017 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Core Lab Test
- ED Point of Care Test
Conditions studied
- Influenza-Like Illness — all drugs for Influenza-Like Illness →
- Influenza — all drugs for Influenza →
Sponsor
Boston Medical Center
Who can join
21 and older, any sex, with Influenza-Like Illness or Influenza. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of the study is to compare Emergency Department patients who undergo influenza testing using an FDA-approved point-of-care device (Cobas Liat Influenza A/B assay) located in the ED, to patients whose samples are sent to the BMC central laboratory. Patients who agree to participate will have their samples randomly assigned to be tested on either at the core lab, or on the POC device. The current turnaround time for samples sent to the laboratory is approximately two hours; investigators expect that the point of care device can reduce this time. Investigators will determine if the time to disposition and the administration of antibiotics is different in the group undergoing POC influenza testing compared to those undergoing laboratory-based influenza testing
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02979730
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Boston Medical Center trials
Trials by the same sponsor.
- NCT06679114 — Preventing Mental Disorders Among Women Internally Displaced by War in Ukraine: The SHAWL Trial · NA · completed
- NCT06093893 — Hypotensive Anesthesia for Orthognathic Surgery · Phase 4 · completed
- NCT06489522 — Parenting Intervention for Mothers With Substance Use Disorder · NA · completed
- NCT05769218 — PrEP and MOUD Rapid Access for Persons Who Inject Drugs: The CHORUS+ Study · NA · recruiting
- NCT06427967 — A Novel Social Emotional Learning Curriculum for Youth With Epilepsy · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02979730 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Boston Medical Center
- Last refreshed: 24 July 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02979730.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing